Research location
Wŏnju
South Korea
Advertisement
Research activity in Wŏnju
South KoreaCureCurrent currently publishes aggregate city-level research activity for this location: 118 trials and 120 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Wŏnju
118 linked trials · page 2 of 3EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart FailureNCT02917031 · 2017-01-10 · 1 site observation
COMPLETED
Immediate Release Versus Slow Release Carvedilol in Heart FailureNCT03209180 · 2016-10-27 · 1 site observation
UNKNOWN
Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic TherapyNCT02855684 · 2016-08-24 · 1 site observation
COMPLETED
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung CancerNCT02754882 · 2016-07-05 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in KoreaNCT02779413 · 2016-06-02 · 1 site observation
COMPLETED
A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.NCT02533453 · 2016-01-28 · 1 site observation
COMPLETED
An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 DiabetesNCT05107063 · 2016-01-20 · 2 site observations
COMPLETED
Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and DyslipidemiaNCT02827903 · 2016-01-15 · 1 site observation
COMPLETED
Foxiga Korea Local Phase 4 StudyNCT02564926 · 2016-01-05 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDNCT02547935 · 2015-09-21 · 1 site observation
COMPLETED
Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)NCT02441933 · 2015-09-01 · 1 site observation
UNKNOWN
Manidipine Versus Amlodipine in Patients With HypertensionNCT03106597 · 2015-08-20 · 1 site observation
TERMINATED
Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPDNCT02343458 · 2015-03-30 · 1 site observation
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 1 site observation
COMPLETED
Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic MedicationsNCT02320721 · 2015-01-01 · 1 site observation
COMPLETED
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin GlargineNCT02294474 · 2015-01-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyNCT02368652 · 2014-12-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate MonotherapyNCT02368665 · 2014-12-01 · 1 site observation
COMPLETED
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With AsthmaNCT02224157 · 2014-11-28 · 1 site observation
COMPLETED
Forxiga (Dapagliflozin) Regulatory Postmarketing SurveillanceNCT02252224 · 2014-09-23 · 1 site observation
COMPLETED
Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02138916 · 2014-06-13 · 1 site observation
COMPLETED
A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South KoreaNCT04980040 · 2014-04-19 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionNCT02059616 · 2014-02-01 · 1 site observation
UNKNOWN
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusNCT01989754 · 2014-01-16 · 1 site observation
COMPLETED
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyNCT01972724 · 2013-12-16 · 1 site observation
COMPLETED
Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes MellitusNCT01821846 · 2013-11-20 · 1 site observation
COMPLETED
A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT01966549 · 2013-11-01 · 1 site observation
COMPLETED
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureNCT01877915 · 2013-09-10 · 1 site observation
COMPLETED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentNCT01894568 · 2013-07-01 · 1 site observation
COMPLETED
Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic PatientsNCT01897051 · 2013-07-01 · 1 site observation
UNKNOWN
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination TherapyNCT01838850 · 2013-04-01 · 1 site observation
COMPLETED
MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptinNCT01792518 · 2013-02-01 · 1 site observation
COMPLETED
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesNCT01715818 · 2012-12-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesNCT01719003 · 2012-10-01 · 1 site observation
COMPLETED
Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- MetforminNCT01632163 · 2012-10-01 · 1 site observation
COMPLETED
A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusNCT01648582 · 2012-07-01 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusNCT01514838 · 2012-04-23 · 1 site observation
TERMINATED
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes PatientsNCT01505426 · 2011-11-28 · 1 site observation
COMPLETED
Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)NCT01431274 · 2011-09-01 · 1 site observation
COMPLETED
TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung CancerNCT01282151 · 2011-07-01 · 1 site observation
TERMINATED
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)NCT01329029 · 2011-05-01 · 1 site observation
COMPLETED
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 DiabetesNCT01289990 · 2011-02-01 · 1 site observation
COMPLETED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation
COMPLETED
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation
COMPLETED
Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 DiabetesNCT01159600 · 2010-07-01 · 1 site observation
COMPLETED
CKD-828 Primary Hypertension Trial(Dose-selection)NCT01128322 · 2010-07-01 · 1 site observation
COMPLETED
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)NCT01147250 · 2010-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.